Predicting Cost-Effectiveness of Generic Versus Brand Dabigatran Using Pharmacometric Estimates among Patients with Atrial Fibrillation in the United States

Ching-Yu Wang, Phuong N. Pham, Sarah Kim, Karthik Lingineni, Stephan Schmidt, Vakaramoko Diaby, Joshua Brown
doi: https://doi.org/10.1101/19006346

Article usage

Article usage: September 2019 to June 2025

AbstractFullPdf
Sep 201921023
Oct 201936047
Nov 201922040
Dec 201934015
Jan 202053062
Feb 202072035
Mar 202099041
Apr 202092046
May 202090017
Jun 20205509
Jul 20202706
Aug 202035013
Sep 20202609
Oct 20202206
Nov 20202329
Dec 20202945
Jan 202132113
Feb 20214545
Mar 20214075
Apr 20215065
May 20215357
Jun 2021461111
Jul 20211889
Aug 202125811
Sep 2021181517
Oct 2021241210
Nov 2021191021
Dec 20211349
Jan 202220514
Feb 20221945
Mar 20221353
Apr 20221015
May 202219810
Jun 202214115
Jul 20221462
Aug 20221653
Sep 20221916
Oct 20222136
Nov 20221243
Dec 20222446
Jan 20231676
Feb 20231464
Mar 2023945
Apr 20234848
May 20231369
Jun 20231341
Jul 2023636
Aug 202318159
Sep 202313109
Oct 2023832
Nov 2023970
Dec 20231029
Jan 20241133
Feb 2024816
Mar 20242044
Apr 20241534
May 20241965
Jun 20241061
Jul 202410412
Aug 202471010
Sep 202417910
Oct 2024715
Nov 202419123
Dec 20249510
Jan 20258521
Feb 2025552310
Mar 2025303018
Apr 2025331013
May 2025161311
Jun 2025320
Back to top
Posted September 20, 2019.
Download PDF

Supplementary Material

Data/Code
Email
Predicting Cost-Effectiveness of Generic Versus Brand Dabigatran Using Pharmacometric Estimates among Patients with Atrial Fibrillation in the United States
Ching-Yu Wang, Phuong N. Pham, Sarah Kim, Karthik Lingineni, Stephan Schmidt, Vakaramoko Diaby, Joshua Brown
medRxiv 19006346; doi: https://doi.org/10.1101/19006346
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area